Endocrinology, Vol 123, 98-105, Copyright © 1988 by Endocrine Society

ARTICLES

Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta

RK Globus, P Patterson-Buckendahl and D Gospodarowicz
Cancer Research Institute, University of California Medical Center, San Francisco 94143.

We have tested the hypothesis that basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF beta) regulate the proliferation of osteoblast-like cells. Cells which migrated from central bone explants of fetal calf calvaria expressed markers characteristic of the osteoblast phenotype, including osteocalcin (bone Gla protein) secretion and increased cAMP production in response to treatment with PTH. Bone cells proliferated in response to bFGF in a dose- and time-dependent pattern (ED50 = 60 pg/ml media). bFGF increased both the rate of bone cell proliferation (1.7-fold above controls) and final cell density at confluence (3-fold above controls). Acidic FGF (aFGF) exerted comparable effects though with lesser potency (ED50 = 2 ng/ml). In addition to its mitogenic effect, bFGF increased the osteocalcin content of conditioned media, suggesting that bFGF also modulates the function of osteoblast-like cells. Although TGF beta did not stimulate bone cell proliferation, it potentiated the mitogenic effects of aFGF and bFGF. In the presence of bFGF (0.7 ng/ml) the response to TGF beta was dose-dependent (ED50 = 1.7 ng/ml), with maximal stimulation at 5 ng/ml. These results demonstrate that aFGF and bFGF are mitogenic for bone cells in vitro. Furthermore, TGF beta potentiates the effects of bFGF and aFGF on the proliferation of bone cells. Since these growth factors are present in bone tissue in vivo, these data support the proposal that FGF and TGF beta may participate in the regulation of bone formation.

This article has been cited by other articles:

				K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF]

				H. L. Wamsley, U. T. Iwaniec, and T. J. Wronski Selected Extraskeletal Effects of Systemic Treatment with Basic Fibroblast Growth Factor in Ovariectomized Rats Toxicol Pathol, August 1, 2005; 33(5): 577 - 583. [Abstract] [Full Text] [PDF]

				G.D.M. Collett and A.E. Canfield Angiogenesis and Pericytes in the Initiation of Ectopic Calcification Circ. Res., May 13, 2005; 96(9): 930 - 938. [Abstract] [Full Text] [PDF]

				Y. Okada, A. Montero, X. Zhang, T. Sobue, J. Lorenzo, T. Doetschman, J. D. Coffin, and M. M. Hurley Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone J. Biol. Chem., May 30, 2003; 278(23): 21258 - 21266. [Abstract] [Full Text] [PDF]

				J. A. Greenwald, B. J. Mehrara, J. A. Spector, S. M. Warren, P. J. Fagenholz, L. P. Smith, P. J. Bouletreau, F. E. Crisera, H. Ueno, and M. T. Longaker In Vivo Modulation of FGF Biological Activity Alters Cranial Suture Fate Am. J. Pathol., February 1, 2001; 158(2): 441 - 452. [Abstract] [Full Text] [PDF]

				P. B. Saadeh, B. J. Mehrara, D. S. Steinbrech, J. A. Spector, J. A. Greenwald, G. S. Chin, H. Ueno, G. K. Gittes, and M. T. Longaker Mechanisms of Fibroblast Growth Factor-2 Modulation of Vascular Endothelial Growth Factor Expression by Osteoblastic Cells Endocrinology, June 1, 2000; 141(6): 2075 - 2083. [Abstract] [Full Text] [PDF]

				H. Liang, S. Pun, and T. J. Wronski Bone Anabolic Effects of Basic Fibroblast Growth Factor in Ovariectomized Rats Endocrinology, December 1, 1999; 140(12): 5780 - 5788. [Abstract] [Full Text]

				F. Blanquaert, A. M. Delany, and E. Canalis Fibroblast Growth Factor-2 Induces Hepatocyte Growth Factor/Scatter Factor Expression in Osteoblasts Endocrinology, March 1, 1999; 140(3): 1069 - 1074. [Abstract] [Full Text]

				M. G. Sabbieti, L. Marchetti, C. Abreu, A. Montero, A. R. Hand, L. G. Raisz, and M. M. Hurley Prostaglandins Regulate the Expression of Fibroblast Growth Factor-2 in Bone Endocrinology, January 1, 1999; 140(1): 434 - 444. [Abstract] [Full Text]

				A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin Biological Roles of Fibroblast Growth Factor-2 Endocr. Rev., February 1, 1997; 18(1): 26 - 45. [Abstract] [Full Text]

				I. D. Dinbergs, L. Brown, and E. R. Edelman Cellular Response to Transforming Growth Factor-beta 1 and Basic Fibroblast Growth Factor Depends on Release Kinetics and Extracellular Matrix Interactions J. Biol. Chem., November 22, 1996; 271(47): 29822 - 29829. [Abstract] [Full Text] [PDF]

				J. M. Boudreaux and D. A. Towler Synergistic Induction of Osteocalcin Gene Expression J. Biol. Chem., March 29, 1996; 271(13): 7508 - 7515. [Abstract] [Full Text] [PDF]

				S Grass, H. Arnold, and T Braun Alterations in somite patterning of Myf-5-deficient mice: a possible role for FGF-4 and FGF-6 Development, January 1, 1996; 122(1): 141 - 150. [Abstract] [PDF]

				C Marcelle, A Eichmann, O Halevy, C Breant, and N. Le Douarin Distinct developmental expression of a new avian fibroblast growth factor receptor Development, January 3, 1994; 120(3): 683 - 694. [Abstract] [PDF]

				D. Frenz, W Liu, J. Williams, V Hatcher, V Galinovic-Schwartz, K. Flanders, and T. Van de Water Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta Development, January 2, 1994; 120(2): 415 - 424. [Abstract] [PDF]